• No results found

Engineering metabolite-responsive transcriptional factors to sense small molecules in eukaryotes: current state and perspectives

N/A
N/A
Protected

Academic year: 2020

Share "Engineering metabolite-responsive transcriptional factors to sense small molecules in eukaryotes: current state and perspectives"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1 Generalized principles of metabolite-responsible transcriptional factors (MRTFs) in biological systems
Fig. 3 Dissecting the design criteria of engineering metabolite responsive transcriptional factors (MRTFs) in eukaryotic cells
Table 1 Representative examples and design principles of engineering metabolite‑responsive transcriptional factors (TFs) in eukaryotes
Table 1 (continued)
+3

References

Related documents

Further information may also be provided by an Employment provider, an Australian Apprenticeships Support Network (Apprenticeship Network) provider, a Group Training Organisation or

Therefore, current study was conducted to assess the effects of nitrogen fertilizer application and plant density on phenology (days to tasseling, silking and maturity) and

The main strategy of adders is that the minimum memory consumption, which is given a priority since there is a need for low density of chips. So in this approach, other than

Research and Development costs increased with €1.3 million compared to H1 2014 and amounted to €6.6 million in the first half year of 2015, General and Administrative costs

Mental health-focused NGOs often have specific expert- ise and experience providing care for people with mental illness in their communities, training and supporting health workers

It should be noted that coding the VSPs of the type B sets in the second LRS scan pass is equivalent to refining the pixels in the list LSP during the refinement pass in

The 2016 annual report from the European Restructuring Monitor (ERM) provides evidence of the employment impact of recent restructuring activity in Europe based on the

TGF- β induced TMEPAI attenuates the response of mesenchymal type TNBC to doxorubicin and paclitaxel, but a minimal effect on cisplatin and bicalutamide.. This is an initial fi nding